Abstract:In invertebrate cells, RNA interference (RNAi) acts as a powerful immune defense that stimulates viral gene knockdown thereby preventing infection. With this pathway, virally produced long dsRNA (dsRNA) is cleaved into short interfering RNA (siRNA) by Dicer and loaded into the RNA-induced silencing complex (RISC) which can then destroy/disrupt complementary viral mRNA sequences. Comparatively, in mammalian cells it is believed that the type I interferon (IFN) pathway is the cornerstone of the innate antiviral response. In these cells, dsRNA acts as a potent inducer of the IFN system, which is dependent on dsRNA length, but not sequence, to stimulate an antiviral state. Although the cellular machinery for RNAi is intact and functioning in mammalian cells, its role to trigger an antiviral response using long dsRNA (dsRNAi) remains controversial. Here we show that dsRNAi is not only functional but has a significant antiviral effect in IFN competent mammalian cells. We found that pre-soaking mammalian cells with concentrations of sequence specific dsRNA too low to induce IFN production could significantly inhibit vesicular stomatitis virus expressing green fluorescent protein (VSV-GFP), and the human coronaviruses (CoV) HCoV-229E and SARS-CoV-2 replication. This phenomenon was shown to be dependent on dsRNA length, was comparable in effect to transfected siRNAs, and could knockdown multiple sequences at once. Additionally, knockout cell lines revealed that functional Dicer was required for viral inhibition, revealing that the RNAi pathway was indeed responsible. These results provide the first evidence that soaking with gene-specific long dsRNA can generate viral knockdown in mammalian cells. We believe that this novel discovery provides an explanation as to why the mammalian lineage retained its RNAi machinery and why vertebrate viruses have evolved methods to suppress RNAi. Furthermore, demonstrating RNAi below the threshold of IFN induction has uses as a novel therapeutic platform, both antiviral and gene targeting in nature.

Inhibition of Measles virus multiplication in cell culture by RNA interference

Lentiviral Vector-Derived Shrnas Confer Enhanced Suppression of Semliki Forest Virus Replication in Bhk-21 Cells Compared to Shrnas Expressed from Plasmids

Piggybac Transposon-Derived Targeting Shrna Interference Against the Bombyx Mori Nucleopolyhedrovirus (Bmnpv)

Efficient Inhibition of Human Cytomegalovirus UL122 Gene Expression in Cell by Small Interfering RNAs

Efficient Inhibition of Human Cytomegalovirus DNA Polymerase Expression by Small Hairpin RNA in Vitro

A Nanomaterial for the Delivery of Dsrna As a Strategy to Alleviate Viral Infections in Maize

Inhibition of Severe Acute Respiratory Syndrome Virus Replication by Small Interfering RNAs in Mammalian Cells

Inhibition of Gene Expression Directed by Small Interfering Rnas in Infectious Bronchitis Virus

Inhibition of Hepatitis B Virus Gene Expression by Single and Dual Small Interfering RNA Treatment

Simultaneously Inhibition of Hiv and Hbv Replication Through A Dual Small Interfering Rna Expression System

Inhibition of Foot and Mouth Disease Virus Replication in Vitro and in Vivo by Dual Short Hairpin RNA-Mediated RNA Interference

Sirna-Mediated Inhibition of Hbv Replication and Expression

Inhibition of Human Metapneumovirus Replication by Small Interfering RNA.

INHIBITION OF HEPATITIS B VIRUS BY COMBINED Sirnas IN VITRO

Inhibition of BmNPV Replication in Bombyx Mori Cell by Dsrna Triggered RNA Interference

Inhibition Of Sars-Cov Gene Expression By Adenovirus-Delivered Small Hairpin Rna

Impact of the Transboundary Interference Inhibitor on RNAi and the Baculovirus Expression System in Insect Cells

Discovery and Use of Long dsRNA Mediated RNA Interference to Stimulate Antiviral Protection in Interferon Competent Mammalian Cells

Inhibition of Influenza Virus Production in Virus-Infected Mice by RNA Interference.

A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference

Inhibition of viral suppressor of RNAi proteins by designer peptides protects from enteroviral infection in vivo